Literature DB >> 11312122

Expression profiling in knockout mice: lymphotoxin versus tumor necrosis factor in the maintenance of splenic microarchitecture.

A N Shakhov1, S A Nedospasov.   

Abstract

Expression profiling provides a powerful approach to define the underlying molecular mechanisms in disease. Several techniques referred collectively to as gene profiling may be also helpful in the analysis of the phenotype of mice with targeted mutations, especially if applied to distinct histological compartments, to specific cell types or to evaluate the effect of specific challenges, such as infection. Here we review several of the existing techniques applicable to genetic knockout studies, and share our experience from the study of mice with tumor necrosis factor (TNF) and lymphotoxin (LT) deficiencies, with specific emphasis on the distinction between TNF- and LT-mediated signalling pathways in vivo. Gene expression profiling analysis of TNF/LT-deficient mice supports the notion that TNF and LT, originally discovered as distinct biological activities, manifest both distinct and redundant functions in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312122     DOI: 10.1016/s1359-6101(01)00004-1

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  2 in total

1.  Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: mice with inactivation of the entire TNF/LT locus versus single-knockout mice.

Authors:  Dmitry V Kuprash; Marat B Alimzhanov; Alexei V Tumanov; Sergei I Grivennikov; Alexander N Shakhov; Ludmila N Drutskaya; Michael W Marino; Regina L Turetskaya; Arthur O Anderson; Klaus Rajewsky; Klaus Pfeffer; Sergei A Nedospasov
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

2.  Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.

Authors:  Roy A Fava; Susan M Kennedy; Sheryl G Wood; Anne I Bolstad; Jadwiga Bienkowska; Adrian Papandile; John A Kelly; Clio P Mavragani; Margaret Gatumu; Kathrine Skarstein; Jeffrey L Browning
Journal:  Arthritis Res Ther       Date:  2011-11-01       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.